Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.
Where this comes from
- Record sourced from PubMed, PMID 28643790.
- Also identified by DOI 10.1038/ncomms16007 and PMC identifier 5489999.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This corrects the article DOI: 10.1038/ncomms14454.